• Montelukast is an oral leukotriene receptor antagonist. It has had a UK licence since 1998 as addon therapy for the treatment of patients, 6 years or older, with mild to moderate asthma inadequately controlled on ‘as required’ short-acting β-agonists and inhaled corticosteroids. It is also licensed for prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstri...

Contrary to the assumption that web browsers are designed to support the user, an examination of a 900,000 distinct PCs shows that web browsers comprise a complex ecosystem with millions of addons collaborating and competing with each other. It is possible for addons to "sneak in" through third party installations or to get "kicked out" by their competitors without user involvement. This study ...

There is a lack of educational technology to support cognitive systems engineering topics such as models of human performance in dynamic environments. This paper describes the Cognitive Systems Engineering Educational Software (CSEES) system, an integrated toolset designed to facilitate curricula related to human judgment and decision-making performance modeling and evaluation. CSEES provides s...

Atypical antipsychotics are increasingly used as first-line treatment for bipolar disorder, in both acute mania and acute depression as well as in maintenance treatment. These have also been shown to be effective as addon agents and in long term prophylaxis. The most common side effects are dry mouth, sedation, dyslipidemia, weight gain, constipation, altered blood glucose level and extra pyram...